Home Patent Forecast® Sectors Log In   Sign Up   Support   Contact  

Pandemics/Epidemics (Free)

Dana-farber Cancer Institute


Dana–Farber Cancer Institute is a comprehensive cancer treatment and research institution in Boston, Massachusetts. Dana-Farber is the founding member of Dana–Farber/Harvard Cancer Center, Harvard's Comprehensive Cancer Center designated by the National Cancer Institute, and one of the 15 clinical affiliates and research institutes of Harvard Medical School.  Dana-Farber researchers are developing antibody therapy for COVID-19 — utilizing a Dana-Farber-developed collection of 27 billion human antibodies against viruses, bacteria, and other bodily invaders. Dana-Farber's prior experience in developing treatments for SARS, MERS, and other viral-borne illnesses gives them a deep level of expertise for attacking this new virus.



News and Insights


Dana-farber Cancer Institute Owned Patent Documents in this Patent Forecast
Loading Documents...